期刊文献+

甲氨蝶呤治疗银屑病性关节炎临床观察 被引量:6

Clinical observation of Methotrexate in the treatment of Psoriatic Arthritis
下载PDF
导出
摘要 目的:观察甲氨蝶呤治疗银屑病性关节炎的疗效及不良反应。方法:选符合标准的该病患者59例,随机分为两组。治疗组予甲氨蝶呤治疗,对照组仅用维A酸类药物外用。结果:治疗组治愈ll例,显效9例,好转8例,无效4例,总有效率为87.5%(95%CI=65.6~97.8%);对照组治愈2例,显效6例,好转5例,无效14例,总有效率为48.1%(95%CI=29.3~66.9%);两组综合疗效比较(Ⅱ=3.2531,P=0.0015),差异显著。结论:甲氨蝶呤治疗银屑病关节炎的临床疗效明显优于外用维A酸类药物,其收益OR=0.13(95%CI=0.04~0.47),NNT=3(95%CI=1.35~3.54)。 Objective:To observe the curative effect of therapy of Methotrexate on psoriatic arthritis.Method :59 cases of sick children suffered from psoriatic arthritis were divided into twogroups randomly.ne treatment group Was treated by Methotrexate.anther control group Was treated by topical tretinoin.Result: In the treatment group 11 cases were cured, 9eases were excellent.8 cases were effective and 4 cases were ineffeetive.The total effective rate Was 87.5%(95%CI=65.6-97.8% ).In the control group 2 eases were cured,6 cases were excellent, 5 cases were effeetiveand 14 eases were ineffective.The total effective rate was 48.1%(95%CI=29.3-66.9% ). Thedifference between the two groups Was significant (H=3.2531 ,P=0.0015).Conclusion:ne eurative effect of Methotrexate with on psoriatic arthritis is better than that of topical tretinoin.OR=0.13 (95%CI=0.04-0.47), NNT=3 ( 95%C 11.35-3.54 ).
出处 《北方药学》 2012年第7期38-39,共2页 Journal of North Pharmacy
关键词 甲氨蝶呤 银屑病 维A酸类药物 Methotrexate Psoriatic Arthritis Topical tretinoin
  • 相关文献

参考文献3

二级参考文献18

  • 1Moll JM, Wright V. Psoriatic arthritis [J]. Semin Arthritis Rheum, 1973,3:55-78. 被引量:1
  • 2Sarzi-Puttini P, Santandrea S, Boccassini L, et al. The role of NSAIDs in psoriatic arthritis: Evidence from a controlled study with nimesulide [J]. Clin Exp Rheumatol, 2001,19 (1 Suppl 22) : 17-20. 被引量:1
  • 3Jones G, Crotty M, Brooks P. Interventions for treating psoriatic arthritis(Cochrane Review)[DB/CD]. The Cochrane Library, Issue 3, 2007. Oxford : Update Software. 被引量:1
  • 4Willkens RF, Williams H J, Ward JR, et al. Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis [J]. Arthritis Rheum, 1984, 27(4) :376-381. 被引量:1
  • 5Whiting-O'Keefe QE, Fye KH, Sack KD. Methotrexate and histologic hepatic abnormalities: A meta-analysis [J]. Am J Med, 1991,90(6):711-716. 被引量:1
  • 6Fraser AD, van Kuijk AW, Westhovens R, et al. A randomized, double blind, placebo controlled muhicentre trial of combination therapy with methotrexate plus cyclosporine in patients with active psoriatic arthritis [J]. Ann Rheum Dis, 2005,64(6) : 859-864. 被引量:1
  • 7Mease PJ, Gladman DD, Keystone EC. Alefacept in combination with methotrexate for the treatment of psoriatic arthritis : Results of a randomized, double-blind, placebo-controlled study [J]. Arthritis Rheum, 2006,54( 5 ) : 1638-1645. 被引量:1
  • 8Fraser SM, Hopkins R, Hunter JA, et al. Sulphasalazine in the management of psoriatic arthritis [J]. Br J Rheumatol, 1993,32(10) :923-925. 被引量:1
  • 9Clegg DO, Reda DJ, Abdellatif M. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: A department of veterans affairs cooperative study [J]. Arthritis Rheum, 1999,42( 11 ) : 2325-2329. 被引量:1
  • 10Nash P, Thaci D, Behrens F, et al. Leflunomide improves psoriasis in patients with psoriatic arthritis: An in-depth analysis of data from the TOPAS study [J]. Dermatology, 2006,212: 238-249. 被引量:1

共引文献60

同被引文献103

引证文献6

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部